Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure

James E Sharman, Eoin O'Brien, Bruce Alpert, Aletta E Schutte, Christian Delles, Michael Hecht Olsen, Roland Asmar, Neil Atkins, Eduardo Barbosa, David Calhoun, Norm R C Campbell, John Chalmers, Ivor Benjamin, Garry Jennings, Stéphane Laurent, Pierre Boutouyrie, Patricio Lopez-Jaramillo, Richard J McManus, Anastasia S Mihailidou, Pedro Ordunez, Raj Padwal, Paolo Palatini, Gianfranco Parati, Neil Poulter, Michael K Rakotz, Clive Rosendorff, Francesca Saladini, Angelo Scuteri, Weimar Sebba Barroso, Myeong-Chan Cho, Ki-Chul Sung, Raymond R Townsend, Ji-Guang Wang, Tine Willum Hansen, Gregory Wozniak, George Stergiou, Lancet Commission on Hypertension Group, James E Sharman, Eoin O'Brien, Bruce Alpert, Aletta E Schutte, Christian Delles, Michael Hecht Olsen, Roland Asmar, Neil Atkins, Eduardo Barbosa, David Calhoun, Norm R C Campbell, John Chalmers, Ivor Benjamin, Garry Jennings, Stéphane Laurent, Pierre Boutouyrie, Patricio Lopez-Jaramillo, Richard J McManus, Anastasia S Mihailidou, Pedro Ordunez, Raj Padwal, Paolo Palatini, Gianfranco Parati, Neil Poulter, Michael K Rakotz, Clive Rosendorff, Francesca Saladini, Angelo Scuteri, Weimar Sebba Barroso, Myeong-Chan Cho, Ki-Chul Sung, Raymond R Townsend, Ji-Guang Wang, Tine Willum Hansen, Gregory Wozniak, George Stergiou, Lancet Commission on Hypertension Group

Abstract

: The Lancet Commission on Hypertension identified that a key action to address the worldwide burden of high blood pressure (BP) was to improve the quality of BP measurements by using BP devices that have been validated for accuracy. Currently, there are over 3000 commercially available BP devices, but many do not have published data on accuracy testing according to established scientific standards. This problem is enabled through weak or absent regulations that allow clearance of devices for commercial use without formal validation. In addition, new BP technologies have emerged (e.g. cuffless sensors) for which there is no scientific consensus regarding BP measurement accuracy standards. Altogether, these issues contribute to the widespread availability of clinic and home BP devices with limited or uncertain accuracy, leading to inappropriate hypertension diagnosis, management and drug treatment on a global scale. The most significant problems relating to the accuracy of BP devices can be resolved by the regulatory requirement for mandatory independent validation of BP devices according to the universally-accepted International Organisation for Standardization Standard. This is a primary recommendation for which there is an urgent international need. Other key recommendations are development of validation standards specifically for new BP technologies and online lists of accurate devices that are accessible to consumers and health professionals. Recommendations are aligned with WHO policies on medical devices and universal healthcare. Adherence to recommendations would increase the global availability of accurate BP devices and result in better diagnosis and treatment of hypertension, thus decreasing the worldwide burden from high BP.

References

    1. Gakidou E, Afshin A, Abajobir AA, Abate KH, Abbafati C, Abbas KM, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390:1345–1422.
    1. Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden. J Hypertens 2006; 24:423–430.
    1. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013; 310:959–968.
    1. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016; 387:957–967.
    1. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 2002; 288:1882–1888.
    1. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 2018; 36:1953–2041.
    1. Haynes RB, Sackett DL, Taylor DW, Gibson ES, Johnson AL. Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med 1978; 299:741–744.
    1. Campbell NR, McKay DW. Accurate blood pressure measurement: why does it matter? CMAJ 1999; 161:277–278.
    1. Jones DW, Appel LJ, Sheps SG, Roccella EJ, Lenfant C. Measuring blood pressure accurately: new and persistent challenges. JAMA 2003; 289:1027–1030.
    1. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: Blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005; 45:142–161.
    1. Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet 2016; 388:2665–2712.
    1. Alpert BS. Can ‘FDA-cleared’ blood pressure devices be trusted? A call to action. Blood Press Monit 2017; 22:179–181.
    1. Campbell NR, Gelfer M, Stergiou GS, Alpert BS, Myers MG, Rakotz MK, et al. A call to regulate manufacture and marketing of blood pressure devices and cuffs: a position statement from the World Hypertension League, International Society of Hypertension and Supporting Hypertension Organizations. J Clin Hypertens (Greenwich) 2016; 18:378–380.
    1. O’Brien E, Alpert BS, Stergiou GS. Accurate blood pressure measuring devices: influencing users in the 21st century. J Clin Hypertens (Greenwich) 2018; 20:1138–1141.
    1. O’Brien E, Stergiou GS, Turner MJ. The quest for accuracy of blood pressure measuring devices. J Clin Hypertens (Greenwich) 2018; 20:1092–1095.
    1. Stergiou GS, Alpert BS, Mieke S, Wang J, O’Brien E. Validation protocols for blood pressure measuring devices in the 21st century. J Clin Hypertens (Greenwich) 2018; 20:1096–1099.
    1. Hodgkinson J, Koshiaris C, Martin U, Mant J, Heneghan C, Hobbs FR, McManus RJ. Accuracy of monitors used for blood pressure checks in English retail pharmacies: a cross-sectional observational study. Br J Gen Pract 2016; 66:e309–e314.
    1. Erdem DG, Erdem E, Dilek M, Aydogdu T, Selim N, Demiray F, et al. Accuracy of sphygmomanometers at pharmacies. Kidney Blood Press Res 2009; 32:231–234.
    1. Ringrose JS, Polley G, McLean D, Thompson A, Morales F, Padwal R. An assessment of the accuracy of home blood pressure monitors when used in device owners. Am J Hypertens 2017; 30:683–689.
    1. Sharman JE, Marwick TH. Accuracy of blood pressure monitoring devices: a critical need for improvement that could resolve discrepancy in hypertension guidelines. J Hum Hypertens 2018; 33:89–93.
    1. Medaval Ltd. Blood pressure monitors. 2018; Dublin, Ireland: Medaval Ltd, . [Accessed 27 September 2017].
    1. Jung MH, Kim GH, Kim JH, Moon KW, Yoo KD, Rho TH, Kim CM. Reliability of home blood pressure monitoring: in the context of validation and accuracy. Blood Press Monit 2015; 20:215–220.
    1. Akpolat T, Dilek M, Aydogdu T, Adibelli Z, Erdem DG, Erdem E. Home sphygmomanometers: validation versus accuracy. Blood Press Monit 2009; 14:26–31.
    1. Dilek M, Adibelli Z, Aydogdu T, Koksal AR, Cakar B, Akpolat T. Self-measurement of blood pressure at home: is it reliable? Blood Press 2008; 17:34–41.
    1. World Health Organisation. Health technologies. Sixtieth World Health Assembly resolution WHA60.29 2007; Geneva, Switzerland: World Health Organisation, . [Accessed 10 January 2019].
    1. World Health Organisation. Regulatory system strengthening for medical products. Sixty-Seventh World Health Assembly resolution WHA67.20 2014; Geneva, Switzerland: World Health Organisation, . [Accessed 10 January 2019].
    1. O’Brien E, Stergiou GS. The pursuit of accurate blood pressure measurement: a 35-year travail. J Clin Hypertens (Greenwich) 2017; 19:746–752.
    1. Association for the Advancement of Medical Instrumentation. The national standard of electronic or automated sphygmomanometers. Arlington, VA: Association for the Advancement of Medical Instrumentation; 1987.
    1. Association for the Advancement of Medical Instrumentation. American National Standard. Electronic or automated sphygmomanometers. Arlington, VA: Association for the Advancement of Medical Instrumentation; 1993.
    1. O’Brien E, Petrie J, Littler W, de Swiet M, Padfield PL, O’Malley K, et al. The British Hypertension Society protocol for the evaluation of automated and semi-automated blood pressure measuring devices with special reference to ambulatory systems. J Hypertens 1990; 8:607–619.
    1. O’Brien E, Petrie J, Littler W, de Swiet M, Padfield P, Altman DG, et al. The British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens 1993; 11: Suppl 2: S43–S62.
    1. Tholl U, Luders S, Bramlage P, Dechend R, Eckert S, Mengden T, et al. The German Hypertension League (Deutsche Hochdruckliga) Quality Seal Protocol for blood pressure-measuring devices: 15-year experience and results from 105 devices for home blood pressure control. Blood Press Monit 2016; 21:197–205.
    1. O’Brien E, Pickering T, Asmar R, Myers M, Parati G, Staessen J, et al. Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Press Monit 2002; 7:3–17.
    1. O’Brien E, Atkins N, Stergiou G, Karpettas N, Parati G, Asmar R, et al. European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit 2010; 15:23–38.
    1. Noninvasive sphygmomanometers – Part 4: Test procedures to determine the overall system accuracy of automated noninvasive sphygmomanometers. European Committee for Standardization EN 1060-4:2004. [Accessed 27 February 2018].
    1. Noninvasive sphygmomanometers: clinical validation of automated measurement type. International Organization for Standardization (ISO) 81060-2, 2009. [Accessed 27 February 2018].
    1. Noninvasive sphygmomanometers – Part 2: Clinical validation of automated measurement type. American National Standards Institute. ANSI/AAMI/ISO 81060-2, 2009. [Accessed 27 February 2018].
    1. Noninvasive sphygmomanometers – Part 2: Clinical investigation of automated measurement type. American National Standards Institute. ANSI/AAMI/ISO 81060-2:2013. [Accessed 27 February 2018].
    1. Stergiou GS, Asmar R, Myers M, Palatini P, Parati G, Shennan A, et al. Improving the accuracy of blood pressure measurement: the influence of the European Society of Hypertension International Protocol (ESH-IP) for the validation of blood pressure measuring devices and future perspectives. J Hypertens 2018; 36:479–487.
    1. McManus R, Lacy P, Clark C, Chapman N, Lewis P. British Irish Hypertension Society Blood Pressure Measurement Working Party. Reporting of blood pressure monitor validation studies. Blood Press Monit 2018; 23:214–215.
    1. Stergiou GS, Alpert B, Mieke S, Asmar R, Atkins N, Eckert S, et al. A universal standard for the validation of blood pressure measuring devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Collaboration Statement. Hypertension 2018; 71:368–374.
    1. International Organization for Standardization. ISO 81060-2:2018. Noninvasive sphygmomanometers – Part 2: Clinical investigation of intermittent automated measurement type. [Accessed 7 December 2018].
    1. O’Brien E, Dolan E, Stergiou GS. Achieving reliable blood pressure measurements in clinical practice: it's time to meet the challenge. J Clin Hypertens (Greenwich) 2018; 20:1084–1088.
    1. Giles TD, Kostis JB, Fernandez C. Blood pressure is a beautiful (but imperfect) biomarker of hypertension. The quixotic quest that fuels the hypertension guideline industry. J Clin Hypertens (Greenwich) 2018; 20:840–841.
    1. Stergiou GS, Parati G, McManus RJ, Head GA, Myers MG, Whelton PK. Guidelines for blood pressure measurement: development over 30 years. J Clin Hypertens (Greenwich) 2018; 20:1089–1091.
    1. Bordley J, 3rd, Connor CA, Hamilton WF, Kerr WJ, Wiggers CJ. Recommendations for human blood pressure determinations by sphygmomanometers. Circulation 1951; 4:503–509.
    1. Medaval, Atkins N. Open letter to experts and manufacturers concerning (EU) 2017/745 and the coalescence of order from chaos. 2018.
    1. Booth J. A short history of blood pressure measurement. Proc R Soc Med 1977; 70:793–799.
    1. Kim H-L, Seo J-B, Chung W-Y, Kim S-H, Kim M-A, Zo J-H. Association between invasively measured central aortic pressure and left ventricular diastolic function in patients undergoing coronary angiography. Am J Hypertens 2015; 28:393–400.
    1. Danchin N, Benetos A, Lopez-Sublet M, Demicheli T, Safar M, Mourad JJ. Aortic pulse pressure is related to the presence and extent of coronary artery disease in men undergoing diagnostic coronary angiography: a multicenter study. Am J Hypertens 2004; 17:129–133.
    1. Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc’h PM, London GM. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002; 39:735–738.
    1. Vlachopoulos C, Aznaouridis K, O’Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010; 15:1865–1871.
    1. Kelly RP, Gibbs HH, O’Rourke MF, Daley JE, Mang K, Morgan JJ, Avolio AP. Nitroglycerin has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery. Eur Heart J 1990; 11:138–144.
    1. Picone DS, Schultz MG, Otahal P, Aakhus S, Al-Jumaily AM, Black JA, et al. Accuracy of cuff-measured blood pressure: systematic reviews and meta-analyses. J Am Coll Cardiol 2017; 70:572–586.
    1. Millasseau S, Agnoletti D. Noninvasive estimation of aortic blood pressures: a close look at current devices and methods. Curr Pharm Des 2015; 21:709–718.
    1. Sharman JE, Avolio AP, Baulmann J, Benetos A, Blacher J, Blizzard CL, et al. Validation of noninvasive central blood pressure devices: ARTERY Society task force consensus statement on protocol standardization. Eur Heart J 2017; 38:2805–2812.
    1. Kumar N, Khunger M, Gupta A, Garg N. A content analysis of smartphone–based applications for hypertension management. J Am Soc Hypertens 2015; 9:130–136.
    1. Goldberg EM, Levy PD. New approaches to evaluating and monitoring blood pressure. Curr Hypertens Rep 2016; 18:49.
    1. Bilo G, Zorzi C, Ochoa Munera JE, Torlasco C, Giuli V, Parati G. Validation of the Somnotouch-NIBP noninvasive continuous blood pressure monitor according to the European Society of Hypertension International Protocol revision 2010. Blood Press Monit 2015; 20:291–294.
    1. Raichle CJ, Eckstein J, Lapaire O, Leonardi L, Brasier N, Vischer AS, Burkard T. Performance of a blood pressure smartphone app in pregnant women: the iPARR trial (iPhone App Compared With Standard RR Measurement). Hypertension 2018; 71:1164–1169.
    1. Chandrasekhar A, Kim CS, Naji M, Natarajan K, Hahn JO, Mukkamala R. Smartphone-based blood pressure monitoring via the oscillometric finger-pressing method. Sci Transl Med 2018; 10:eaap8674.
    1. Butlin M, Shirbani F, Barin E, Tan I, Spronck B, Avolio AP. Cuffless estimation of blood pressure: importance of variability in blood pressure dependence of arterial stiffness across individuals and measurement sites. IEEE Trans Biomed Eng 2018; 65:2377–2383.
    1. Mukkamala R, Hahn JO, Inan OT, Mestha LK, Kim CS, Toreyin H, Kyal S. Toward ubiquitous blood pressure monitoring via pulse transit time: theory and practice. IEEE Trans Biomed Eng 2015; 62:1879–1901.
    1. Nair D, Tan SY, Gan HW, Lim SF, Tan J, Zhu M, et al. The use of ambulatory tonometric radial arterial wave capture to measure ambulatory blood pressure: the validation of a novel wrist-bound device in adults. J Hum Hypertens 2008; 22:220–222.
    1. Lee SS, Nam DH, Hong YS, Lee WB, Son IH, Kim KH, Choi JG. Measurement of blood pressure using an arterial pulsimeter equipped with a Hall device. Sensors 2011; 11:1784–1793.
    1. Wang C, Li X, Hu H, Zhang L, Huang Z, Lin M, et al. Monitoring of the central blood pressure waveform via a conformal ultrasonic device. Nat Biomed Eng 2018; 2:687–695.
    1. Shuren J, Patel B, Gottlieb S. FDA regulation of mobile medical apps. JAMA 2018; 320:337–338.
    1. WHO Global Model Regulatory Framework for Medical Devices including in vitro diagnostic medical devices: WHO Medical device technical series 2017. [Accessed 28 January 2019].
    1. US Food and Drug Administration: regulatory harmonization and convergence. [Accessed 26 January 2019].
    1. British and Irish Hypertension Society. BP monitors. 2017/2018; Leicester, UK: BIHS, . [Accessed 4 December 2018].
    1. Hypertension Canada. Blood pressure devices recommended by Hypertension Canada. 2018; Markham, Ontario, Canada: Hypertension Canada, . [Accessed 4 December 2018].
    1. AMA. AHA developing list of validated BP monitors. [Accessed 15 August 2018].

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa